Keywords: eucardic, gains, additional, indication, uk, medicines, control

Eucardic gains additional indication

Article | 07 January 2002

The UK Medicines Control Agency has approved Roche's comprehensiveanti-adrenergic inhibitor Eucardic (carvedilol) for use in the treatment of patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Carvedilol

Coreg

Go to drug listing